Display options
Share it on

Adv Funct Mater. 2012 Dec 05;22(23):4879-4890. doi: 10.1002/adfm.201200864. Epub 2012 Jul 09.

Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery.

Advanced functional materials

Ryan F Donnelly, Thakur Raghu Raj Singh, Martin J Garland, Katarzyna Migalska, Rita Majithiya, Cian M McCrudden, Prashant Laxman Kole, Tuan Mazlelaa Tuan Mahmood, Helen O McCarthy, A David Woolfson

Affiliations

  1. School of Pharmacy, Queens University Belfast 97 Lisburn Road, Belfast BT9 7BL, UK.

PMID: 23606824 PMCID: PMC3627464 DOI: 10.1002/adfm.201200864

Abstract

Unique microneedle arrays prepared from crosslinked polymers, which contain no drug themselves, are described. They rapidly take up skin interstitial fluid upon skin insertion to form continuous, unblockable, hydrogel conduits from attached patch-type drug reservoirs to the dermal microcirculation. Importantly, such microneedles, which can be fabricated in a wide range of patch sizes and microneedle geometries, can be easily sterilized, resist hole closure while in place, and are removed completely intact from the skin. Delivery of macromolecules is no longer limited to what can be loaded into the microneedles themselves and transdermal drug delivery is now controlled by the crosslink density of the hydrogel system rather than the stratum corneum, while electrically modulated delivery is also a unique feature. This technology has the potential to overcome the limitations of conventional microneedle designs and greatly increase the range of the type of drug that is deliverable transdermally, with ensuing benefits for industry, healthcare providers and, ultimately, patients.

References

  1. Toxicol In Vitro. 2005 Oct;19(7):957-62 - PubMed
  2. Expert Opin Drug Deliv. 2005 May;2(3):533-48 - PubMed
  3. J Control Release. 2005 Mar 21;103(2):381-92 - PubMed
  4. Anesthesiology. 2001 Dec;95(6):1356-61 - PubMed
  5. Drug Dev Ind Pharm. 2009 Oct;35(10):1242-54 - PubMed
  6. Int J Pharm. 2009 Jan 5;365(1-2):26-33 - PubMed
  7. Adv Drug Deliv Rev. 2004 Mar 27;56(5):581-7 - PubMed
  8. Pharm Res. 2011 Jan;28(1):41-57 - PubMed
  9. Pharm Res. 2011 Jan;28(1):82-94 - PubMed
  10. Pharm Res. 2011 Aug;28(8):1919-30 - PubMed
  11. Recent Pat Drug Deliv Formul. 2010 Jan;4(1):1-17 - PubMed
  12. J Control Release. 2010 Nov 1;147(3):333-41 - PubMed
  13. J Pharm Pharmacol. 2008 Jan;60(1):27-33 - PubMed
  14. J Control Release. 2009 Oct 1;139(1):63-72 - PubMed
  15. Expert Rev Med Devices. 2011 Jul;8(4):459-82 - PubMed
  16. J Chromatogr B Biomed Appl. 1996 Mar 3;677(2):305-12 - PubMed
  17. Biomaterials. 2008 May;29(13):2113-24 - PubMed
  18. Int J Pharm. 2009 Aug 13;378(1-2):93-100 - PubMed
  19. Biomed Microdevices. 2009 Feb;11(1):35-47 - PubMed
  20. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jun 1;879(19):1713-6 - PubMed
  21. Int J Pharm. 1999 Nov 25;191(1):65-74 - PubMed
  22. Int J Pharm. 2012 Sep 15;434(1-2):80-9 - PubMed
  23. Contact Dermatitis. 1994 Nov;31(5):281-7 - PubMed
  24. J Pharmacokinet Biopharm. 1986 Feb;14(1):95-106 - PubMed
  25. J Pharm Pharmacol. 2010 Jul;62(7):829-37 - PubMed
  26. Int J Pharm. 2011 Mar 15;406(1-2):91-8 - PubMed
  27. Eur J Pharm Sci. 2008 Oct 2;35(3):193-202 - PubMed
  28. J Control Release. 2007 Apr 2;118(2):189-95 - PubMed
  29. Exp Dermatol. 2000 Jun;9(3):165-9 - PubMed

Publication Types

Grant support